Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
WGO. WGO Practice Guideline - Gastroesophageal Reflux Disease (GERD) 2015. Available from: http://www.worldgastroenterology.org/guidelines/global-guidelines/gastroesophageal-reflux-disease.
Habr F, Raker C, Lin CL, Zouein E, Bourjeily G. Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: a secondary analysis. Clin Res Hepatol Gastroenterol. 2013 Feb;37(1):93-9. doi: 10.1016/j.clinre.2012.03.036.
Heidelbaugh JJ. Gastroesophageal Reflux Disease (GERD). Ambulatory Clinical Guidelines Oversight. 2018. Available from: https://www.med.umich.edu/1info/FHP/practiceguides/gerd/gerd.12.pdf.
Rayner C. Dealing with gastro–oesophageal reflux disease during pregnancy. Med Today. 2005;6:65-66.
Turan I, Kitapcioglu G, Tavmergen Goker E, et al. In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease. United European Gastroenterol J. 2016 Apr;4(2):221-8. doi: 10.1177/2050640615597836.
Malferttheiner SF, Malfertheiner MV, Kropf S, Costa SD, Malfertheiner P. A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol. 2012 Sep 24;12:131. doi: 10.1186/1471-230X-12-131.
Shehtman MN, Korot'ko GF, Burkov SG. Physiology and pathology of digestive organs in pregnant women. Tashkent: Medicine; 1989. 158 p.
Grishenko VI, Sherbina NA, Lipko OP, et al. Techenie beremennosti i rodov pri ekstragenital'nykh zabolevaniiakh [Course of pregnancy and childbirth in case of extragenital diseases]. Kharkov; 1992. 191 p.
Fajer AB, Holzbauer M, Newport HM. The contribution of the adrenal gland to the total amount of progesterone produced in the female rat. J Physiol. 1971 Apr;214(1):115-26. doi: 10.1113/jphysiol.1971.sp009422.
Dolk H, Loane M, Teljeur C, et al. Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system. Eur J Epidemiol. 2015 Nov;30(11):1153-64. doi: 10.1007/s10654-015-0012-y.
Justina VD, Gonçalves JS, David FL, Giachini FR, Lima VV. Evaluation of drug prescriptions for pregnant women in the Legal Amazon Region. Rev Bras Saude Mater Infant. 2018;18(4). doi: 10.1590/1806-93042018000400004.
FDA News Release. FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products. Available from: https://www.fda.gov/drugs/labeling/pregnancy-and-lactation-labeling-drugs-final-rule. Accessed August 1, 2019.
FDA Consumer Articles. Pregnant? Breastfeeding? Better Drug Information Is Coming. Available from: https://www.fda.gov/consumers/consumer-updates/pregnant-breastfeeding-better-drug-information-coming. Accessed August 1, 2019.
Mospan C. New Prescription Labeling Requirements for the Use of Medications in Pregnancy and Lactation. CE for Pharmacists. The Ohio Pharmacist Foundation. Accessed August 1, 2019. [Internet]. Available from: https://cdn.ymaws.com/www.wsparx.org/resource/resmgr/CE_Magazine/WA_0416_State_CE_Lesson.pdf
Australian government: Therapeutic Goods Administration. Prescribing medicines in pregnancy database. 2019. Available from: https://www.tga.gov.au/prescribing-medicines-pregnancy-database.
Categories of drugs for pregnancy. 2019. Available from: https://uk.wikipedia.org/wiki/.
Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol. 1999 Sep 1;150(5):476-81. doi:10.1093/oxfordjournals.aje.a010036.
Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med. 2000 Aug 10;343(6):445-6. doi:10.1056/NEJM200008103430616.
Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009 Jun 11;360(24):2528-35. doi: 10.1056/NEJMoa0807154.
Gill SK, O'Brien L, Einarson TR, Koren G. Safety of proton pump inhibitors (PPIs) during pregnancy: a meta-analysis. Am J Gastroenterol. 2009 Jun;104(6):1541-5; quiz 1540, 1546. doi: 10.1038/ajg.2009.122.
Habr F, Raker C, Lin CL, Zouein E, Bourjeily G. Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: a secondary analysis. Pediatr Gastroenterol Hepatol Nutr. 2019 Mar;22(2):107-121. doi: 10.5223/pghn.2019.22.2.107.